BioCryst Pharmaceuticals
BCRX
BCRX
197 hedge funds and large institutions have $1.48B invested in BioCryst Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 66 increasing their positions, 67 reducing their positions, and 28 closing their positions.
Holders
197
Holders Change
+2
Holders Change %
+1.03%
% of All Funds
3.46%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.04%
New
32
Increased
66
Reduced
67
Closed
28
Calls
$90.6M
Puts
$53.1M
Net Calls
+$37.5M
Net Calls Change
+$24.2M
Top Buyers
| 1 |
1
Two Sigma Advisers
New York
|
$27.6M |
| 2 |
2
Fisher Asset Management
Camas,
Washington
|
$43.2M |
| 3 |
3
State Street
Boston,
Massachusetts
|
$102M |
| 4 |
MB
4
MPM BioImpact
Boston,
Massachusetts
|
$10.1M |
| 5 |
5
Norges Bank
Oslo,
Norway
|
$11.4M |
